Mitchell Shawnte, Chief Legal Officer at Olema Pharmaceuticals ($OLMA), made two open market sales of company shares in the last year, totaling nearly $946,000. His latest sale occurred on March 4, 2026. These transactions rank him 5,060th among 11,678 insiders by sale value, well below the average of $8.6 million across 6.4 sales per person. He recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Mitchell Shawnte | CHIEF LEGAL OFFICER | M | Stock Option (Right to Buy) | 25000 | $0.00 | 410,000.0000 | 85,732,221 | 5.75% | 0.03% |
| March 4, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Mitchell Shawnte | CHIEF LEGAL OFFICER | S | Common Stock | 24767 | $24.25 | 233.0000 | 85,732,221 | 99.07% | 0.03% |
| March 4, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Mitchell Shawnte | CHIEF LEGAL OFFICER | S | Comon Stock | 233 | $24.69 | 0.0000 | 85,732,221 | 100.00% | 0.00% |
| March 3, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Mitchell Shawnte | CHIEF LEGAL OFFICER | M | Stock Option (Right to Buy) | 15000 | $0.00 | 435,000.0000 | 85,732,221 | 3.33% | 0.02% |
| March 3, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Mitchell Shawnte | CHIEF LEGAL OFFICER | M | Common Stock | 15000 | $4.37 | 15,000.0000 | 85,732,221 | 9999.99% | 0.02% |
| March 3, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Mitchell Shawnte | CHIEF LEGAL OFFICER | S | Common Stock | 15000 | $23.01 | 0.0000 | 85,732,221 | 100.00% | 0.02% |
| March 4, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Mitchell Shawnte | CHIEF LEGAL OFFICER | M | Common Stock | 25000 | $4.37 | 25,000.0000 | 85,732,221 | 9999.99% | 0.03% |
| Feb. 2, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Mitchell Shawnte | CHIEF LEGAL OFFICER | A | Stock Option (Right to Buy) | 220000 | $0.00 | 220,000.0000 | 85,732,221 | 9999.99% | 0.26% |
| Feb. 2, 2026 | Olema Pharmaceuticals, Inc. | $OLMA | Mitchell Shawnte | CHIEF LEGAL OFFICER | A | Performance Stock Options (Right to Buy) | 56250 | $0.00 | 56,250.0000 | 85,732,221 | 9999.99% | 0.07% |
| Feb. 28, 2025 | Olema Pharmaceuticals, Inc. | $OLMA | Mitchell Shawnte | CHIEF LEGAL OFFICER | A | Stock Option (Right to Buy) | 450000 | $0.00 | 450,000.0000 | 58,743,522 | 9999.99% | 0.77% |